FierceBiotech: AVERROES trial terminated early: apixaban associated with "important" relative risk reduction for stroke and systemic embolism i
- #news
- #headline
FierceBiotech: AVERROES trial terminated early: apixaban associated with "important" relative risk reduction for stroke and systemic embolism i
Captured 2026-08-16 from FierceBiotech. The archived copy is preserved so this citation survives link rot.